Cargando…
COVID-19 associated mucormycosis – An emerging threat
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly become a global threaten since its emergence in the end of 2019. Moreover, SARS-CoV-2 infection could also present with co-infection or secondary infection by other virus, bacteria, or...
Autores principales: | Chao, Chien-Ming, Lai, Chih-Cheng, Yu, Wen-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755409/ https://www.ncbi.nlm.nih.gov/pubmed/35074291 http://dx.doi.org/10.1016/j.jmii.2021.12.007 |
Ejemplares similares
-
Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021) -
Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19
por: Maassarani, Deoda, et al.
Publicado: (2022) -
Monkeypox: An emerging global threat during the COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2022) -
COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022) -
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022)